Minor ginsenosides, such as compound K, Rg
3(
S), which can be produced by deglycosylation of ginsenosides Rb
1, showed strong anti-cancer effects. However, the anticancer effects of gypenoside LXXV, which is one of the deglycosylated shapes of ginsenoside Rb
[...] Read more.
Minor ginsenosides, such as compound K, Rg
3(
S), which can be produced by deglycosylation of ginsenosides Rb
1, showed strong anti-cancer effects. However, the anticancer effects of gypenoside LXXV, which is one of the deglycosylated shapes of ginsenoside Rb
1, is still unknown due to the rarity of its content in plants. Here, we cloned and characterized a novel ginsenoside-transforming
β-glucosidase (BglG167b) derived from
Microbacterium sp. Gsoil 167 which can efficiently hydrolyze gypenoside XVII into gypenoside LXXV, and applied it to the production of gypenoside LXXV at the gram-scale with high specificity. In addition, the anti-cancer activity of gypenoside LXXV was investigated against three cancer cell lines (HeLa, B16, and MDA-MB231) in vitro. Gypenoside LXXV significantly reduced cell viability, displaying an enhanced anti-cancer effect compared to gypenoside XVII and Rb
1. Taken together, this enzymatic method would be useful in the preparation of gypenoside LXXV for the functional food and pharmaceutical industries.
Full article
